{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:04Z","timestamp":1753891024386,"version":"3.41.2"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011512","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01274","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T08:44:31Z","timestamp":1597135471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women"],"prefix":"10.3389","volume":"11","author":[{"given":"Kimone Leigh","family":"Fisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Mabuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Sivro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinaye","family":"Ngcapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Ann Shelley","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzana","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongiwe","family":"Ndlovu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quarraisha","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S.","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derseree","family":"Archary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"volume-title":"UNAIDS Global HIV and AIDS statistics-2018 fact sheet","year":"2019","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"2010","author":"Abdool Karim","year":"2010","journal-title":"Science."},{"key":"B4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/infdis\/jis422","article-title":"Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis","volume":"206","author":"Kersh","year":"2012","journal-title":"J Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jiv110","article-title":"Antibody maturation in women who acquire HIV infection while using antiretroviral preexposure prophylaxis","volume":"212","author":"Laeyendecker","year":"2015","journal-title":"J Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/QAI.0b013e31824f53a9","article-title":"Preservation HIV-1-specific IFN\u03b3+ CD4+ T cell responses in breakthrough infections following exposure to Tenofovir Gel in the CAPRISA 004 microbicide trial","volume":"60","author":"Mureithi","year":"2012","journal-title":"J Acquir Immune Defici Syndr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/QAD.0000000000001812","article-title":"Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity","volume":"32","author":"Chung","year":"2018","journal-title":"AIDS."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/QAI.0000000000001477","article-title":"The association of HIV-1 Gag-specific IgG antibodies with natural control of HIV-1 infection in individuals not carrying HLA-B* 57:01 is only observed in viremic controllers","volume":"76","author":"Tjiam","year":"2017","journal-title":"J Acqu Immune Defic Syndr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0165-2478(97)85532-0","article-title":"Prognostic value of antibodies to p66 during the course of HIV1 infection","volume":"1","author":"Moja","year":"1997","journal-title":"Immunol Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/QAD.0b013e32835cb720","article-title":"Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective'human leukocyte antigen-B alleles in HIV controllers","volume":"27","author":"French","year":"2013","journal-title":"AIDS."},{"key":"B13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2010.12.044","article-title":"Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection","volume":"412","author":"Isitman","year":"2011","journal-title":"Virology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/mi.2015.145","article-title":"Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel","volume":"9","author":"Archary","year":"2016","journal-title":"Muc Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"a007039","DOI":"10.1101\/cshperspect.a007039","article-title":"The antibody response against HIV-1","volume":"2","author":"Overbaugh","year":"2012","journal-title":"Cold Spring Harbor Persp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci Trans Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1371\/journal.ppat.1005101","article-title":"Mucosal B cells are associated with delayed SIV acquisition in vaccinated female but not male rhesus macaques following SIVmac251 rectal challenge","volume":"11","author":"Tuero","year":"2015","journal-title":"PLoS Pathog."},{"key":"B20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"Barouch","year":"2013","journal-title":"Cell."},{"key":"B21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1126\/science.aab3886","article-title":"Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys","volume":"349","author":"Barouch","year":"2015","journal-title":"Science."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.aag0491","article-title":"Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus","volume":"353","author":"Liu","year":"2016","journal-title":"Science."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.4049\/jimmunol.182.2.1202","article-title":"Rapid degranulation of NK cells following activation by HIV-specific antibodies","volume":"182","author":"Chung","year":"2009","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.1016048108","article-title":"Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure","volume":"108","author":"Chung","year":"2011","journal-title":"Proc Natl Acad Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jim.2018.03.007","article-title":"Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC","volume":"457","author":"Worley","year":"2018","journal-title":"J Immunol Methods."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1002739","DOI":"10.1371\/journal.ppat.1002739","article-title":"HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads","volume":"8","author":"Mabuka","year":"2012","journal-title":"PLoS Pathog."},{"key":"B27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.chom.2015.03.002","article-title":"Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality","volume":"17","author":"Milligan","year":"2015","journal-title":"Cell Host Microbe."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1086\/425582","article-title":"Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads","volume":"190","author":"Nag","year":"2004","journal-title":"J Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1086\/338828","article-title":"Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1-infected women","volume":"185","author":"Battle-Miller","year":"2002","journal-title":"J Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0140-6736(11)60878-7","article-title":"Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women","volume":"378","author":"Abdool Karim","year":"2011","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jim.2010.12.016","article-title":"A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples","volume":"366","author":"Ackerman","year":"2011","journal-title":"J Immunol Methods."},{"key":"B32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH 1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1005817","DOI":"10.1371\/journal.ppat.1005817","article-title":"Antibody-mediated internalization of infectious HIV-1 virions differs among antibody isotypes and subclasses","volume":"12","author":"Tay","year":"2016","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/mi.2013.23","article-title":"Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques","volume":"7","author":"Moog","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/infdis\/172.3.691","article-title":"Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection","volume":"172","author":"B\u00e9lec","year":"1995","journal-title":"J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1073\/pnas.1012861108","article-title":"Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection","volume":"108","author":"Li","year":"2011","journal-title":"Proc Natl Acad Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1128\/JVI.00410-10","article-title":"Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian\/human immunodeficiency virus SHIV89","volume":"84","author":"Xiao","year":"2010","journal-title":"J Virol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.4049\/jimmunol.0803115","article-title":"Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat\/Env compared with multigenic vaccines","volume":"182","author":"Florese","year":"2009","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/nm.1974","article-title":"Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques","volume":"15","author":"Hessell","year":"2009","journal-title":"Nat Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1000433","DOI":"10.1371\/journal.ppat.1000433","article-title":"Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers","volume":"5","author":"Hessell","year":"2009","journal-title":"PLoS Pathog."},{"key":"B41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"Mascola","year":"2000","journal-title":"Nat Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"228ra38","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Trans Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1004185","DOI":"10.1371\/journal.pcbi.1004185","article-title":"Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees","volume":"11","author":"Choi","year":"2015","journal-title":"PLoS Comput Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1005315","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control","volume":"12","author":"Ackerman","year":"2016","journal-title":"PLoS Pathog."},{"key":"B45","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","article-title":"Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers","volume":"23","author":"Lambotte","year":"2009","journal-title":"AIDS."},{"key":"B46","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.157.5.2168","article-title":"HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression","volume":"157","author":"Baum","year":"1996","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"53629","DOI":"10.1371\/journal.pone.0053629","article-title":"Analysis of V2 antibody responses induced in vaccinees in the ALVAC\/AIDSVAX HIV-1 vaccine efficacy trial","volume":"8","author":"Zolla-Pazner","year":"2013","journal-title":"PLoS ONE."},{"key":"B48","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1128\/JVI.00156-14","article-title":"HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities","volume":"88","author":"Pollara","year":"2014","journal-title":"J Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1128\/JVI.03765-13","article-title":"Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity","volume":"88","author":"Liu","year":"2014","journal-title":"J Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/aid.2009.0223","article-title":"IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines","volume":"26","author":"Banerjee","year":"2010","journal-title":"AIDS Res Hum Retrovir."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.4049\/jimmunol.1402918","article-title":"Viremic HIV controllers exhibit high plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibody responses against HIV-1 p24 associated with greater antibody isotype diversification","volume":"194","author":"Tjiam","year":"2015","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e101863","DOI":"10.1371\/journal.pone.0101863","article-title":"HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities","volume":"9","author":"Seaton","year":"2014","journal-title":"PloS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e00700","DOI":"10.1128\/JVI.00700-17","article-title":"HIV-1 Env-and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV","volume":"91","author":"Madhavi","year":"2017","journal-title":"J Virol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2989\/16085906.2016.1196224","article-title":"Combination HIV prevention options for young women in Africa","volume":"15","author":"Baxter","year":"2016","journal-title":"Afric J AIDS Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/mi.2009.89","article-title":"HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis","volume":"2","author":"Tudor","year":"2009","journal-title":"Muc Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e01552","DOI":"10.1128\/JVI.01552-17","article-title":"HIV-1-specific IgA monoclonal antibodies from an HIV-1 vaccinee mediate galactosylceramide blocking and phagocytosis","volume":"92","author":"Wills","year":"2018","journal-title":"J Virol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:42:35Z","timestamp":1696520555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2020.01274"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01274","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"article-number":"1274"}}